β-Muricholic Acid

目录号: GC40719纯度: >98.00%同义词: Β-鼠胆酸,5β-Cholanic Acid-3α,6β,7β-triol, β-MCA
β-胆酸β-muricholic acid是一种天然存在的三羟基亲水性胆汁酸,作为胆道胆固醇去饱和剂,促进胆固醇胆结石的溶解。

β-Muricholic Acid
Cas No.: 2393-59-1
规格价格库存数量操作
1mg¥1,386.00现货
1
5mg¥2,772.00现货
1
10mg¥4,858.00现货
1
10mM (in 1mL DMSO)¥1,860.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

β-Muricholic acid is a naturally occurring trihydroxy hydrophilic bile acid, as a biliary cholesterol-desaturating agent and facilitates the dissolution of cholesterol gallstones. It found in mice and differs from human primary bile acids by featuring a hydroxyl group in the β- configuration at the 6-position[1-3].

β-muricholic acid(100 µM;48h) inhibited lipid accumulation in primary-cultured mouse hepatocytes after exposure to palmitic acid (PA)/oleic acid (OA), it may be useful in the treatment of nonalcohol fatty liver disease (NAFLD) [4].

β-muricholic acid(0.5% β-muricholic acid in food; p.o; 8 weeks) is more effective than UDCA in enhancing the dissolution rates of cholesterol gallstones via increasing a liquid crystals-containing phase. Addition of beta-muricholic acid decreased gallstone prevalence to 20% through significantly reducing biliary secretion rate, saturation index, and intestinal absorption of cholesterol that prevented the transition of cholesterol from its liquid crystalline phase to solid crystals and stones [5].

[1]. Denk GU, Kleiss CP, et,al. Tauro-β-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential. Biochem Biophys Res Commun. 2012 Aug 10;424(4):758-64. doi: 10.1016/j.bbrc.2012.07.029. Epub 2012 Jul 15. PMID: 22809502.
[2]. Montet JC, Parquet M, et,al. beta-Muricholic acid; potentiometric and cholesterol-dissolving properties. Biochim Biophys Acta. 1987 Mar 13;918(1):1-10. doi: 10.1016/0005-2760(87)90002-6. PMID: 3828364.
[3]. Sacquet E, Parquet M, et,al. Metabolism of beta-muricholic acid in man. Steroids. 1985 May;45(5):411-26. doi: 10.1016/0039-128x(85)90006-6. PMID: 3834660.
[4]. Takada S, Matsubara T, et,al. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. Lab Invest. 2021 Feb;101(2):193-203. doi: 10.1038/s41374-020-00509-x. Epub 2020 Dec 10. PMID: 33303970.
[5]. Wang DQ, Tazuma S. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res. 2002 Nov;43(11):1960-8. doi: 10.1194/jlr.m200297-jlr200. PMID: 12401895.

β-胆酸β-muricholic acid是一种天然存在的三羟基亲水性胆汁酸,作为胆道胆固醇去饱和剂,促进胆固醇胆结石的溶解。它在小鼠中发现,不同于人类的原胆汁酸,它在6位的β-结构中具有羟基[1-3]

β-muricholic acid(100 µM;48h)可抑制暴露于棕榈酸(PA)/油酸(OA)后的原代培养小鼠肝细胞的脂质积累, 可能对治疗非酒精性脂肪肝(NAFLD)有用[4]

β-muricholic acid(0.5% β-muricholic acid in food; p.o; 8 weeks)通过增加含液晶相,比UDCA更有效地提高胆固醇胆结石的溶解速率, 添加β-muricholic acid可显著降低胆汁分泌率、饱和指数和肠道对胆固醇的吸收,从而阻止胆固醇从液晶状态转变为固体晶体和结石,从而使胆结石患病率降至20%[5]

实验参考方法 Experimental Reference Method

Cell experiment [1]:

Cell lines

Primary hepatocytes

Preparation Method

Hepatocytes were exposed to 100 µM β-muricholic acid after treatment with palmitic acid (PA)/oleic acid (OA).

Reaction Conditions

100 µM;48h

Applications

β-muricholic acid inhibited lipid accumulation in primary-cultured mouse hepatocytes after exposure to palmitic acid (PA)/oleic acid (OA).

Animal experiment [2]:

Animal models

Male C57L/J mice

Preparation Method

For gallstone dissolution study, mice that have formed cholesterol gallstones were fed chow (control) with or without 0.5% ursodeoxycholic acid (UDCA) or 0.5% β-muricholic acid for 8 weeks.

Dosage form

0.5% β-muricholic acid in food; p.o; 8 weeks

Applications

β-muricholic acid is more effective than UDCA in enhancing the dissolution rates of cholesterol gallstones via increasing a liquid crystals-containing phase.

References:
[1]:Takada S, Matsubara T, et,al. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. Lab Invest. 2021 Feb;101(2):193-203. doi: 10.1038/s41374-020-00509-x. Epub 2020 Dec 10. PMID: 33303970.
[2]:Wang DQ, Tazuma S. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res. 2002 Nov;43(11):1960-8. doi: 10.1194/jlr.m200297-jlr200. PMID: 12401895.

产品文档 Product Documents

Purity:>98.00%

化学性质Chemical Properties

CAS 号
2393-59-1
同义词
Β-鼠胆酸,5β-Cholanic Acid-3α,6β,7β-triol, β-MCA
化学名
(5β)-3α,6β,7β-trihydroxy-cholan-24-oic acid
SMILES
OC(CC[C@@H](C)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@@H](O)[C@@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C)=O
分子式
C24H40O5
分子量
408.6 g/mol
溶解性
20mg/ml in ethanol & DMSO, 30mg/ml in DMF
保存条件
Store at -20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol